Miralax and Zopiclone drug interactions - a phase IV clinical study of FDA data
Drug interactions are reported among people who take Miralax and Zopiclone. Common interactions include urinary tract infection among females and anhedonia among males.
The phase IV clinical study analyzes what interactions people who take Miralax and Zopiclone have. It is created by eHealthMe based on reports of 32 people who take Miralax and Zopiclone from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
32 people who take Miralax and Zopiclone together, and have interactions are studied.
What is Miralax?
Miralax has active ingredients of polyethylene glycol 3350. It is often used in constipation. eHealthMe is studying from 72,714 Miralax users for its effectiveness, alternative drugs and more.
What is Zopiclone?
Zopiclone has active ingredients of eszopiclone. It is often used in insomnia. eHealthMe is studying from 42,597 Zopiclone users for its effectiveness, alternative drugs and more.
Number of Miralax and Zopiclone reports submitted per year:
Common Miralax and Zopiclone drug interactions by gender *:
- Urinary tract infection
- Urine output increased
- Weight decreased
- Abdominal pain
- Balance disorder
- Decreased appetite
- Renal failure
- Rotator cuff repair
- Spinal cord injury
- Upper limb fracture
- Aortic aneurysm
- Arteriovenous malformation
Common Miralax and Zopiclone drug interactions by age *:
- Pancreatitis relapsing
- Bone density decreased
- Carpal tunnel syndrome
- Chronic kidney disease
- Emotional distress
- Hip arthroplasty
- Abdominal discomfort
- Abscess limb
- Anal abscess
- Chest pain
- Functional gastrointestinal disorder
- Initial insomnia
- Middle insomnia
- Muscular weakness
- Pain in extremity
- Saliva discolouration
Common conditions people have *:
- Immunodeficiency Common Variable: 5 people, 15.62%
- Sleep Disorder: 4 people, 12.50%
- Pain: 4 people, 12.50%
- Nausea (feeling of having an urge to vomit): 3 people, 9.38%
- Hiv Infection: 3 people, 9.38%
- Thyroid Cancer: 2 people, 6.25%
- Rectal Cancer (cancer of rectum): 2 people, 6.25%
- Pulmonary Oedema (fluid accumulation in the lungs): 2 people, 6.25%
- Psoriasis (immune-mediated disease that affects the skin): 2 people, 6.25%
- Primary Immunodeficiency Syndrome: 2 people, 6.25%
* Approximation only. Some reports may have incomplete information.
Do you take Miralax and Zopiclone?Personalize this study to your gender and age
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Lai SW, Lai HC, Lin CL, Liao KF, "Zopiclone use associated with increased risk of acute pancreatitis: a case–control study in Taiwan", International journal of clinical practice, 2015 Nov .
Alternative drugs to, pros and cons of the 2 drugs:
Browse all drug interactions of Miralax and Zopiclone:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Miralax interactions:
Browse all interactions between Miralax and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Zopiclone interactions:
Browse all interactions between Zopiclone and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
How the study uses the data?
The study uses data from the FDA. It is based on polyethylene glycol 3350 and eszopiclone (the active ingredients of Miralax and Zopiclone, respectively), and Miralax and Zopiclone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Miralax and Zopiclone.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Lipiodol and Norvasc drug interaction - 23 seconds ago
- Prilosec vs. Pantoprazole Sodium - 31 seconds ago
- Rivaroxaban and Tresiba drug interaction - 33 seconds ago
- Ninlaro and Fish Oil drug interaction - 50 seconds ago
- Nevirapine and Epidermal Necrolysis - 51 seconds ago
- Insulin and Porokeratosis - 51 seconds ago
- Soma vs. Robaxin-750 - 54 seconds ago
- Xalatan and Appetite Increased - a minute ago
- Efavirenz and Mouth Ulcers - a minute ago
- Divalproex and Headache - a minute ago